# SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA202388** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2025-12-02
## Drug
- **FDA Application Number:** ANDA202388
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Active ingredients:** METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ
- **Manufacturer:** Sandoz Inc
- **First approval:** 2025-12-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202388)
---
*MORVS · CC0 1.0*